Reproductive factors of ovarian and endometrial cancer risk in a high fertility population in Mexico
- PMID: 10446978
Reproductive factors of ovarian and endometrial cancer risk in a high fertility population in Mexico
Abstract
A case-control study was carried out in Mexico City during 1995-1997 among women with epithelial ovarian cancer (84 cases) and endometrial cancer (85 cases). The control group consisted of 668 healthy women, matched according to age categories. In a multivariate analysis, the reproductive risk factors for ovarian and endometrial cancer are similar. The risk of ovarian cancer was inversely related to the number of full-term pregnancies; the odds ratio (OR) was 0.17 and the 95% confidence interval (CI) was 0.05-0.54 when comparing nulliparous women versus those with more than seven pregnancies. For endometrial cancer, a similar association was observed (OR, 0.11; 95% CI, 0.04-0.34). The use of oral contraceptive hormones was inversely associated with both ovarian (OR, 0.36; 95% CI, 0.15-0.83) and endometrial cancer risk (OR, 0.36; 95% CI, 0.14-0.90). In women with a history of more than 8.7 years without ovulation, the risk of ovarian cancer decreased four times (OR, 0.23; 95% CI, 0.10-0.50), and that of endometrial cancer decreased more than five times (OR, 0.17; 95% CI, 0.08-0.35). These two neoplasms are clearly typified as hormone dependent, and it is possible to establish that "ovulation" and "exfoliative" mechanisms jointly determine the level of risk for both ovarian and endometrial cancer.
Similar articles
-
Risk factors for ovarian cancer in central Italy.Gynecol Oncol. 2000 Oct;79(1):50-4. doi: 10.1006/gyno.2000.5909. Gynecol Oncol. 2000. PMID: 11006030
-
Sex steroids and breast cancer prevention.J Natl Cancer Inst Monogr. 1994;(16):139-47. J Natl Cancer Inst Monogr. 1994. PMID: 7999456 Review.
-
Menstrual and reproductive factors in relation to risk of endometrial cancer in Chinese women.Cancer Causes Control. 2006 Sep;17(7):949-55. doi: 10.1007/s10552-006-0034-6. Cancer Causes Control. 2006. PMID: 16841262
-
Timing of pregnancy and the risk of epithelial ovarian cancer.Cancer Epidemiol Biomarkers Prev. 2003 Jan;12(1):42-6. Cancer Epidemiol Biomarkers Prev. 2003. PMID: 12540502
-
Hormone replacement therapy and cancer.Gynecol Endocrinol. 2001 Dec;15(6):453-65. Gynecol Endocrinol. 2001. PMID: 11826770 Review.
Cited by
-
Age at last birth and risk of developing epithelial ovarian cancer: a meta-analysis.Biosci Rep. 2019 Sep 13;39(9):BSR20182035. doi: 10.1042/BSR20182035. Print 2019 Sep 30. Biosci Rep. 2019. PMID: 31471530 Free PMC article.
-
Deciphering the Therapeutic Applications of Nanomedicine in Ovarian Cancer Therapy: An Overview.Curr Drug Deliv. 2024;21(9):1180-1196. doi: 10.2174/0115672018253815230922070558. Curr Drug Deliv. 2024. PMID: 37818568 Review.
-
Development of a multi-marker model combining HE4, CA125, progesterone, and estradiol for distinguishing benign from malignant pelvic masses in postmenopausal women.Tumour Biol. 2016 Feb;37(2):2183-91. doi: 10.1007/s13277-015-4037-3. Epub 2015 Sep 9. Tumour Biol. 2016. PMID: 26349751
-
Breastfeeding and Endometrial Cancer Risk: An Analysis From the Epidemiology of Endometrial Cancer Consortium.Obstet Gynecol. 2017 Jun;129(6):1059-1067. doi: 10.1097/AOG.0000000000002057. Obstet Gynecol. 2017. PMID: 28486362 Free PMC article.
-
Breastfeeding and the incidence of endometrial cancer: A meta-analysis.Oncotarget. 2015 Nov 10;6(35):38398-409. doi: 10.18632/oncotarget.5049. Oncotarget. 2015. PMID: 26384296 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical